Cargando…

Preoperative Total Serum Cholesterol and Patients' Survival in Resected Nonsmall Cell Lung Cancer

The association between hypocholesterolemia and lung cancer risk has been confirmed in some studies. The purpose of the study was to determine whether preoperative hypocholesterolemia (below normal range) is a prognostic factor for survival after nonsmall cell lung cancer (NSCLC) resection. Two hund...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomita, Masaki, Ayabe, Takanori, Shimizu, Tetsuya, Nakamura, Kunihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437391/ https://www.ncbi.nlm.nih.gov/pubmed/26316934 http://dx.doi.org/10.1155/2012/463520

Ejemplares similares

Serum Carcinoembryonic Antigen Level Predicts Cancer-Specific Outcomes of Resected Non-Small Cell Lung Cancer With Interstitial Pneumonia
por: Tomita, Masaki, et al.
Publicado: (2018)

Low Body Mass Index Is an Independent Predictive Factor after Surgical Resection in Patients with Non-Small Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2017)

The Prognostic Values of a Novel Preoperative Inflammation-Based Score in Japanese Patients With Non-Small Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2019)

Intrathoracic scapular dislocation following lung cancer resection
por: Tomita, Masaki, et al.
Publicado: (2018)

Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2017)

Comparison of Inflammation-Based Prognostic Scores in Patients undergoing Curative Resection for Non-small Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2018)

The Inflammatory Prognostic Index Predicts Cancer-Specific Outcomes of Patients with Resected Non-Small Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2018)

Does Obesity-Related Hemodilution of Carcinoembryonic Antigen Exist in Non-Small Cell Lung Cancer Patients?
por: Tomita, Masaki, et al.
Publicado: (2017)

Emergent Completion Pneumonectomy for Postoperative Hemorrhage from Rupture of the Infected Pulmonary Artery in Lung Cancer Surgery
por: Ayabe, Takanori, et al.
Publicado: (2011)

Combination of Advanced Lung Cancer Inflammation Index and C-Reactive Protein Is a Prognostic Factor in Patients With Operable Non-Small Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2017)

Isolated Renal Metastasis from Non-Small-Cell Lung Cancer: Report of 2 Cases
por: Tomita, Masaki, et al.
Publicado: (2015)

Resected thymic large cell neuroendocrine carcinoma: A case report and review of the literature
por: Ogata, Shogo, et al.
Publicado: (2019)

Port-site implantation of Type A Masaoka Stage I thymoma after video-assisted thoracic surgery: a case report
por: Nose, Naohiro, et al.
Publicado: (2016)

Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1
por: Tomita, Masaki, et al.
Publicado: (2017)

A case of spontaneous hemopneumothorax in which the condition worsened after chest drainage
por: Nose, Naohiro, et al.
Publicado: (2018)

Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival
por: Tomita, Masaki, et al.
Publicado: (2001)

Pathologic Correlation of Serum Carcinoembryonic Antigen and Cytokeratin 19 Fragment in Resected Nonsmall Cell Lung Cancer
por: Lee, Seokkee, et al.
Publicado: (2013)

Survival outcomes of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected nonsmall cell lung cancer: FAST-nab
por: Marushima, Hideki, et al.
Publicado: (2020)

Prognostic value of serum high‐density lipoprotein cholesterol elevation in nonsmall cell lung cancer patients receiving radical surgery
por: Luo, Fan, et al.
Publicado: (2020)

Cost-effectiveness analysis of positron-emission tomography-computed tomography in preoperative staging for nonsmall-cell lung cancer with resected monometastatic disease
por: Zeng, Xiaohui, et al.
Publicado: (2019)

Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
por: Tfayli, Arafat, et al.
Publicado: (2020)

Survival Prediction Model Using Clinico-Pathologic Characteristics for Nonsmall Cell Lung Cancer Patients After Curative Resection
por: Wu, Ching-Yang, et al.
Publicado: (2015)

Is major pathologic response sufficient to predict survival in resectable nonsmall‐cell lung cancer patients receiving neoadjuvant chemotherapy?
por: Cai, Jing‐Sheng, et al.
Publicado: (2021)

Role of gender in the survival of surgical patients with nonsmall cell lung cancer
por: Scaglia, Nóris C., et al.
Publicado: (2013)

Can Inflammatory and Nutritional Serum Markers Predict Chemotherapy Outcomes and Survival in Advanced Stage Nonsmall Cell Lung Cancer Patients?
por: Cehreli, Ruksan, et al.
Publicado: (2019)

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
por: Kristiansen, G, et al.
Publicado: (2003)

Genetic Variations in Key MicroRNAs are Associated With the Survival of Nonsmall Cell Lung Cancer
por: Wu, Shuangshuang, et al.
Publicado: (2015)

The Tumor-immune Index is Correlated With the Prognosis of Patients After Curative Resection for Nonsmall Cell Lung Cancer
por: Li, Bobo, et al.
Publicado: (2015)

Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung Cancer
por: Tohi, Makiko, et al.
Publicado: (2023)

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer
por: Kaira, K, et al.
Publicado: (2008)

Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017)

Modern therapies of nonsmall cell lung cancer
por: Jachowski, Andrzej, et al.
Publicado: (2023)

Effect of mu Agonists on Long-Term Survival and Recurrence in Nonsmall Cell Lung Cancer Patients
por: Wang, Kai, et al.
Publicado: (2015)

Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer?
por: Cistaro, Angelina, et al.
Publicado: (2013)

Primary mucinous adenocarcinoma of the thymus: A case report
por: Hamahiro, Tomoka, et al.
Publicado: (2021)

Pulmonary torsion after resuscitative thoracotomy: a case report
por: Hara, Daisuke, et al.
Publicado: (2021)

TP53 Mutations in Nonsmall Cell Lung Cancer
por: Mogi, Akira, et al.
Publicado: (2011)

Signatures of Drug Sensitivity in Nonsmall Cell Lung Cancer
por: Gong, Hua C., et al.
Publicado: (2011)

The Role of Proteasome Inhibition in Nonsmall Cell Lung Cancer
por: Escobar, Mauricio, et al.
Publicado: (2011)

Gemcitabine for the treatment of advanced nonsmall cell lung cancer
por: Toschi, Luca, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_016hgq4m6aj3m184vvc7mm1ho8